Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Your doctor may recommend staggered initiation, starting with a low semaglutide dose while maintaining stable testosterone dosing, allowing your body to adapt to the GLP-1 effect
Lets go over all of these things and more before you jump into making the switch
Overview Retatrutide (LY3437943) is a novel, long-acting triple receptor agonist peptide that simultaneously targets the Glucose-dependent Insulinotropic Polypeptide (GIP) receptor, Glucagon-like Peptide-1 (GLP-1) receptor, and the Glucagon (GCGR) receptor
Proposed Mechanisms (Preclinical) Incretin & Islet Biology GIP receptor activation: Studied for potentiation of glucose-dependent insulin secretion and effects on -cell function in metabolic models
Hypothetical synergy, research ongoing
